Voyager Acquisition, a blank check company targeting the healthcare sector, lowered the proposed deal size for its upcoming IPO on Tuesday.
The New York, NY-based company now plans to raise $220 million by offering 22 million units at $10. The company had previously filed to offer 26.1 million units at $10. Each unit consists of one share of common stock and one-half of a warrant, exercisable at $11.50. At the revised terms, Voyager Acquisition will raise -16% less in proceeds than previously anticipated.
The company is led by CEO and Director Adeel Rouf, a former Investment Professional at Cohen and Company Asset Management, and Chairman Warren Hosseinion, who currently serves as President of Nutex Health and previously co-founded Apollo Medical Holdings. It plans to target the healthcare and healthcare-related industries, focusing on businesses with enterprise values between $160 million and $2 billion.
Voyager Acquisition was founded in 2023 and plans to list on the Nasdaq under the symbol VACHU. Cantor Fitzgerald is the sole bookrunner on the deal.
